(Q54391705)

29 May 2018

title

[Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium]. (English)

1 reference

29 May 2018

main subject

angiogenesis inhibitor

1 reference

M Kernt

1

1 reference

29 May 2018

S Thiele

2

1 reference

29 May 2018

C Hirneiss

3

1 reference

29 May 2018

A S Neubauer

4

1 reference

29 May 2018

C A Lackerbauer

5

1 reference

29 May 2018

A Wolf

6

1 reference

29 May 2018

K H Eibl

7

1 reference

29 May 2018

C Haritoglou

8

1 reference

29 May 2018

M W Ulbig

9

1 reference

29 May 2018

A Kampik

10

1 reference

29 May 2018

language of work or name

German

0 references

publication date

1 May 2011

1 reference

29 May 2018

published in

Ophthalmologe

1 reference

29 May 2018

volume

108

1 reference

29 May 2018

issue

5

1 reference

29 May 2018

page(s)

445-451

1 reference

29 May 2018

VEGF modulation of retinal pigment epithelium resistance

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

The pathogenesis of edema in diabetic maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Oxidative damage and protection of the RPE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

BAY 43-9006 inhibition of oncogenic RET mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Measuring patient's quality of life in ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Pathogenesis of lesions in late age-related macular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Mechanisms of fluid accumulation in retinal edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Role of growth factors and the wound healing response in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

The tight junction: a multifunctional complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Inhibitors of ocular neovascularization: promises and potential problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Vascular endothelial growth factors and angiogenesis in eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00347-010-2304-7

Age-related macular degeneration

21 January 2018

1 reference

12 December 2020

Growth characteristics and ultrastructure of human retinal pigment epithelium in vitro.

1 reference

12 December 2020

Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in germany: Model analysis from the perspective of germany's statutory health insurance system

1 reference

12 December 2020

Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor

1 reference

12 December 2020

Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population

1 reference

12 December 2020

Global data on visual impairment in the year 2002

1 reference

12 December 2020

Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study.

1 reference

12 December 2020

1 reference

12 December 2020

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion

1 reference

12 December 2020

Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways

1 reference

12 December 2020

Age-related macular degeneration

1 reference

12 December 2020

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1

1 reference

12 December 2020

Regulation of angiogenesis via vascular endothelial growth factor receptors.

1 reference

12 December 2020

Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor

1 reference

12 December 2020

Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2.

1 reference

12 December 2020

Indocyanine green increases light‐induced oxidative stress, senescence, and matrix metalloproteinases 1 and 3 in human RPE cells

1 reference

12 December 2020

In vitro behaviour of the pigmented cells of the retina and uvea of the adult human eye

1 reference

12 December 2020

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

12 December 2020

Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases

1 reference

12 December 2020

Sunlight and age-related macular degeneration. The Beaver Dam Eye Study

1 reference

12 December 2020

Oxidative damage and age-related macular degeneration

1 reference

12 December 2020

Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

12 December 2020

Ranibizumab combined with low-dose sorafenib for exudative age-related macular degeneration

1 reference

12 December 2020

10.1007/S00347-010-2304-7

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018